Cancer is a complex disease whose outcome depends largely on the cross-talk between the
tumor and its microenvironment. Here, we review the evolution of the field of tumor …

The adoptive transfer of natural killer (NK) cells is an emerging therapy in the field of
immuno-oncology. In the last 3 decades, NK cells have been utilized to harness the anti …

The role of haploidentical hematopoietic cell transplantation (HCT) using posttransplant
cyclophosphamide (PTCy) for acute lymphoblastic leukemia (ALL) is being defined. We …

Background Acute graft-versus-host disease (aGVHD) remains the major cause of early
mortality after haploidentical related donor (HID) hematopoietic stem cell transplantation …

Ruxolitinib is an important treatment for steroid refractory graft-versus-host disease (SR-
GVHD). Therefore, we reported the updated results of a systematic review and meta …

Background The outcome of chemotherapy in patients older than 40 years with acute
lymphoblastic leukaemia is poor and myeloablative allogeneic haematopoietic stem-cell …

There is limited evidence regarding the association between graft-versus-host disease
(GVHD) and reduced relapse in patients who undergo allogeneic hematopoietic stem cell …

Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell malignancy,
and allogeneic hematopoietic stem cell transplantation (allo‐HSCT) is the only curable …

Late acute graft-versus-host disease (GVHD) is defined as de novo acute GVHD presenting
beyond 100 days after allogeneic hematopoietic cell transplantation (HCT) without …

Cytomegalovirus reactivation (CMVR) after allogeneic hematopoietic cell transplantation
(HCT) is a frequent complication related to survival outcomes; however, its impact on …